Chromie Health, a developer of an AI-powered scheduling and staffing management platform for hospital operations, raised $2 million in a pre-seed round led by AIX Ventures.
The funding comes amidst strong demand from 750 hospitals on the waitlist for the service and will fuel the Chromie’s development of a full suite of intelligent agents designed to streamline workflows and optimize workforce management. The startup has already filled more than 35,000 last-minute shifts, helping hospital clinical teams fill nursing gaps faster than traditional manual methods.
“Since deploying Chromie Dispatch, our unit has significantly streamlined last-minute scheduling needs. No more scrambling through call logs or paying exorbitant agency rates,” said Sarah Mitchell, Nurse Manager at St Joseph’s Hospital. “Our staff feels supported, and we’ve already seen a 25% reduction in overtime costs.”
Founded in 2024 and headquartered in New York, Chromie Health is developing a full suite of intelligent AI agents to optimize workforce management, streamline administrative workflows, and improve patient outcomes.
“Chromie Health is building the iOS operating system for healthcare: an AI-native agent layer that orchestrates communication, coordination, and workforce operations across the hospital,” said Krish Ramadurai, Partner at AIX Ventures. “By replacing fragmented legacy workflows with a seamless no-code, SMS-native platform, Chromie has the potential to become foundational infrastructure for modern healthcare systems and unlock billions in enterprise value.”
AI-powered digital health software startups have secured billions of dollars in funding so far in 2026, according to our latest funding database.
More recently, Optura, a provider of an enterprise AI platform that helps healthcare organizations quickly assess the business value of AI and prioritize AI investments in real time, raised $17.5 million in a Series A round. In another deal, XCaliber Health, a developer of an agentic operating system purpose-built to reduce administrative burden and improve the quality of clinical care delivered to patients, raised $6.5 million in Seed funding.